Maunank Shah, MD, PhD

Dr. Shah is a Professor in the Division of Infectious Diseases at Johns Hopkins (JH) School of Medicine, and a faculty member of both the JH Center for Clinical Global Health Education and the JH Center for TB Research. He is Medical Director for the Baltimore City Tuberculosis Program, an attending physician at the Johns Hopkins Hospital, and is board certified in infectious diseases and internal medicine. 

Dr. Shah’s research involves evaluating and implementing novel HIV and tuberculosis (TB) intervention strategies in resource constrained settings. He has evaluates new TB diagnostic technologies (examples include the urinary LAM assays, Xpert MTB/Rif, Quantiferon-gold-in-tube) and assesses the cost-effectiveness of emerging strategies for HIV and TB care in South Africa, Uganda, India, and Baltimore.  He has expertise in conducting economic evaluations, and he has lead efforts to develop mathematical transmission models to examine the economic and epidemiological impact of the HIV continuum of care domestically and globally (www.jheem.org).  Additionally, his research interests include evaluating the use of mobile health (mHealth) technologies to optimize adherence to TB therapy.  He is a co-inventor of an electronic DOT (directly observed therapy) platform (www.emocha.com) to allow HIPAA compliant, patient-centered video-based asynchronous directly observed therapy (DOT) and improved case management for patients with TB.  In collaboration with emocha Mobile Health Inc, he is evaluating the role of miDOT for improving HIV and TB outcomes in Maryland, as well as around the globe, with a goal to leverage these innovative approaches to improve patient outcomes for a variety of infectious and chronic diseases. 

Dr. Shah serves on the Maryland Tuberculosis Guidelines committee, has led evidence review for WHO TB diagnostics guidelines, on urinary LAM usage, and he leads online TB educational activities at the Center for Clinical Global Health Education. He is committed to teaching and mentoring, and is a 2016 recipient of the Johns Hopkins Center for Global Health's Faculty Advising Award, and was inducted into the Distinguished Teaching Society of Johns Hopkins University in 2017. He has been an invited speaker at numerous international and domestic conferences, medical and public health schools, and other educational forums, and received the 2020 National TB Controllers Association Robert Koch Award and the 2019 David Glasser Award for TB control.  Additionally, Dr. Shah serves as co-director for the microbiology and infectious disease curriculum for students at Johns Hopkins School of Medicine. Dr. Shah also serves as a clinical TB expert and provides medical consultations for the CDC funded Regional TB Center of Excellence (COE) for the Northeast region (Global TB Institute).

He is the inventor and principal investigator for HIV-ASSIST (HIV Antiretroviral Selection Support and Interactive Search Tool), an online interactive site that allows for patient centered, individualized, and evidence-based decision making and education for providers choosing ART regimens for people living with HIV (www.HIV-ASSIST.com), and has advised the development of an online electronic TB consultation platform (www.rutgers.idcrowd.org) for the Northeast regional CDC funded TB COE.

He is Associate Editor for the open source journal for the Infectious Disease Society of America—OFID, and he is an author of more than 60 peer-reviewed studies. He is a member of the International Union for TB and Lung Disease, the International AIDS Society, and the Infectious Diseases Society of America.

Dr. Shah earned his PhD in clinical investigation and public health, with expertise in decision-analysis, epidemiology, and biostatistics, from the Johns Hopkins Bloomberg School of Public Health. He completed his infectious diseases fellowship at Johns Hopkins School of Medicine and his internal medicine residency at Emory University, where he also served as Chief Resident. He received his MD from the University of California, San Francisco, and a BS in biology from the University of Virginia.